On Wednesday, December 3, the Sensex and Nifty 50 are expected to open on a muted note, despite gains in global markets.
GIFT Nifty hovered near the 26,207 mark, showing a premium of about 1 point over the previous close of Nifty futures. This signalled a muted opening for the Indian equity indices.
Take Solutions share price is likely to be in focus after the stock surged to a fresh 52-week high on Tuesday, marking an impressive 100% gain on a year-to-date basis (2025). With this the stock's new peak, the share price has now reached its highest level in 21 months.
Here is the price chart of Take Solutions, showing how the stock has performed in 2025
Take Solutions is a healthcare-focused company, engaged in technology-led services for the Life Sciences and Supply Chain Management sectors, including clinical research support, generics assistance, regulatory submissions, and pharmacovigilance.
The company declared its quarterly numbers on October 27, 2025. Take Solutions posted no operating revenue for Q2 FY26, similar to Q2 FY25, while Q1 FY26 had reported a small ₹0.04 crore revenue figure, indicating muted operational activity in the latest quarter.
Despite the absence of operational revenue, the company recorded a consolidated net profit of ₹6.29 crore in Q2 FY26, a reversal from the ₹1.58 crore loss reported a year earlier. The bottom line also improved sequentially, moving from a ₹0.91 crore loss in Q1 FY26 to a profit in the September quarter.
The profit for the quarter was largely attributed to gains from discontinued operations of its wholly owned subsidiary, Ecron Acunova Limited (EAL).
On November 10, 2025, Take Solutions Limited announced a significant change in its Promoter group shareholding. As per the November 8, 2025 disclosure, Esyspro Infotech Limited, a Promoter group entity, sold its entire stake in an off-market transaction executed on November 6, 2025. The entity divested 75,40,998 shares, valued at ₹52,78,698 (excluding taxes, brokerage, or other charges), reducing its holding from 5.10% (7,540,998 shares) to zero, marking a complete exit from the company.
Founded in 2000 and based in Chennai, Take Solutions Limited operates as a global technology firm specializing in Life Sciences and Supply Chain Management. The company combines industry expertise with technology solutions to deliver services across clinical, regulatory, safety, and supply chain functions.
Historically, its Life Sciences operations covered full-service CRO activities—clinical trials, BA/BE studies, regulatory filings, and pharmacovigilance—while its supply chain segment focused on engineering support, collaboration tools, process automation, and product re-engineering through proprietary platforms.
The company caters to pharmaceutical, biotech, medical device, and generics manufacturers across India, the US, Europe, and other global markets, supported by delivery centers and domain-rich capabilities.
Take Solutions Limited, with a market cap of ₹490 crore, jumped by 1.88% on Tuesday. The stock reached a new 52-week high. The stock price has hit a back-to-back 52-week high over the previous week.
The Nifty Small-Cap index has given only 0.83% returns in the last 3 months, while inthe year 2025, it has posted negative returns of 5.35%
In the last 3 months, the stock price of Take Solutions has given multibagger returns of 200%. Over the past year and six months, the company has produced returns of 94% and 289%, respectively.
For android only